An observational study in Lymphedema, sponsored by Taizhou Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Taizhou Hospital · Observational
The aim of this study is to further explore the optimal screening factors for functional lymphatic vessels in lymphaticovenous anastomosis in patients with lymphedema.
By analyzing the size of lymphatic vessels (0.3-0.6mm), ICG imaging, contraction characteristics of lymphatic vessels and lymphatic flow in patients with lymphedema, the effect of functional lymphatic vessel selection on lymphatic drainage in patients with lymphedema was judged during operation, so as to provide a more scientific basis for the selection of functional lymphatic vessels in clinical surgery.
561 studies on the registry are indexed under Lymphedema; 136 are open to participants now.
This study's enrollment of 41 is below the median of 106 across 144 observational studies indexed under Lymphedema.
Browse Lymphedema studies →Taizhou Hospital is the lead sponsor of 23 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Aged 18-80 years; Lymphedema and swelling of the limbs for more than 3 months
Exclusion Criteria:
lymphaticovenous anastomosis
Rate of size(0.3-0.6mm)
size of lymphatic vessels
Time frame: through study completion, an average of 2.5 year
Rate of lymphatic vessels contractility
When observing lymphatic vessels in fluorescence mode, a contraction occurring within 10 seconds is considered as contractility positive
Time frame: through study completion, an average of 2.5 year
Rate of flow
while the presence of lymphatic fluid flowing out after cutting the lymphatic vessel is considered as flow positive
Time frame: through study completion, an average of 2.5 year
Rate of ICG
When observing lymphatic vessels in fluorescence mode, lymphatic vessel fluorescence is considered as ICG positive
Time frame: through study completion, an average of 2.5 year
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Taizhou Hospital